Top

Tag: featured


Industry, Vaccines

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

November 23, 2020

Via: World Pharma News

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported […]


FDA, Regulations

FDA said to plan early December advisory meetings to discuss Covid-19 vaccines ahead of potential authorization

November 18, 2020

Via: CNBC

The Food and Drug Administration has asked a group of advisors to set aside three days in early December for potential meetings to discuss Covid-19 vaccines — a key step in the agency’s authorization process, according to two people familiar […]


Clinical Trials, Research and Development

New Technique Developed to Study Cell Types in Parkinson’s Disease

November 17, 2020

Via: Genetic Engineering and Biotechnology News

Parkinson’s disease (PD) is a progressive disorder that affects nerve cells in the brain responsible for body movement. When dopamine-producing neurons die, symptoms such as tremor, slowness, stiffness, and balance problems occur. Researchers at Carnegie Mellon University (CMU) have developed […]


Cell and Gene Therapy, Industry

Boosting Capabilities in Gene and Cell Therapy Bioprocessing

November 17, 2020

Via: Genetic Engineering and Biotechnology News

A new company has been founded to supply software for managing cell & gene therapy manufacturing. Autolomous, founded in February 2019, has already secured four different clients whom they hope to assist with digitizing and streamlining their workflows. “There’s a […]


Industry, Vaccines

Moderna COVID-19 Vaccine 94.5% Effective in Early Phase III Data

November 16, 2020

Via: Genetic Engineering and Biotechnology News

Moderna said today that its COVID-19 vaccine candidate mRNA-1273 passed its most important test, the 30,000+ patient Phase III COVE trial (NCT04470427), by showing itself to be 94.5% effective in preventing COVID-19—an outcome hailed by CEO Stéphane Bancel as a […]


Cell and Gene Therapy, Industry

New Therapeutic Target Identified for Breast Cancer Treatment

November 16, 2020

Via: Genetic Engineering and Biotechnology News

Lemur tyrosine kinase 3 (LMTK3) is associated with cell proliferation and endocrine resistance in breast cancer. Now, a team of researchers from the University of Sussex has completed a five-year study that provides evidence for a potential new target for […]


FDA, Regulations

FDA grants emergency authorisation to Lilly’s COVID-19 antibody

November 11, 2020

Via: Pharma Times

Bamlanivimab is now available under emergency use for the treatment of mild to moderate COVID-19 in adults and paediatric patients 12 years and older who are at high risk of progressing to severe COVID-19 and/or hospitalisation. In a statement, Lilly […]


Clinical Trials, Research and Development

Nerve Cell Growth Powered by Printable Ink May Aid Nerve Injury

November 11, 2020

Via: Genetic Engineering and Biotechnology News

Nerve tissue engineering is an application of tissue engineering in peripheral nerve regeneration, and tissue-engineered nerve grafts, like other tissue-engineered constructs, are typically composed of a nerve scaffold combined with cellular and/or molecular components. A team of researchers from RMIT […]


Industry, Vaccines

BIO Chairman: FDA Vaccine Reviews Too Complex and Costly for States to Replicate

November 10, 2020

Via: BioSpace

Several states have pledged to review COVID-19 vaccines themselves, after U.S. Food and Drug Administration (FDA) Emergency Use Authorizations EUA), to ensure safety and efficacy. A robust review, however, is unlikely. In reality, if state reviews go forward, they most […]


Industry, Vaccines

Coronavirus vaccine frontrunner Pfizer delivers key trial data – here’s where the other vaccines stand

November 9, 2020

Via: CNBC

Numerous pharmaceutical companies are racing to complete clinical trials and become the first to successfully get U.S. approval for a vaccine to fight the coronavirus, which has infected more than 50.5 million people worldwide in 11 months. A safe and […]


Clinical Trials, Research and Development

Antibody-Drug Combination Regresses Pancreatic Tumor in Mice

November 9, 2020

Via: Genetic Engineering and Biotechnology News

According to the National Cancer Institute, about 10% of patients with pancreatic cancer (PC) remain alive five years after diagnosis. Tumor size has a strong impact on survival rates. The larger the tumor, the less likely it is to be […]


Cell and Gene Therapy, Industry

Scientists use gene therapy to regenerate damaged optic nerve fibers

November 5, 2020

Via: Medical News

Scientists have used gene therapy to regenerate damaged nerve fibers in the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the leading causes of blindness worldwide. Axons – nerve fibers – in […]